Patent details
EP2632908 Title: SULFONAMIDES AS HIV PROTEASE INHIBITORS
Basic Information
- Publication number:
- EP2632908
- PCT Application Number:
- PCT/CA/2011/001206
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP118354018
- PCT Publication Number:
- WO/2012/055034
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SULFONAMIDES AS HIV PROTEASE INHIBITORS
- French Title of Invention:
- SULFONAMIDES EN TANT QU'INHIBITEURS DE LA PROTÉASE DU VIH
- German Title of Invention:
- SULFONAMIDE ALS HIV-PROTEASEHEMMER
- SPC Number:
Dates
- Filing date:
- 27/10/2011
- Grant date:
- 25/05/2016
- EP Publication Date:
- 25/05/2016
- PCT Publication Date:
- 03/05/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/09/2013
- EP B1 Publication Date:
- 25/05/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/10/2016
- Expiration date:
- 27/10/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/10/2011
- Name:
- Merck Canada Inc.
- Address:
- 16711 Trans-Canada Highway, Kirkland, QC H9H 3L1, Canada (CA)
Inventor
1
- Name:
- LEBRUN Marie-Eve
- Address:
- Canada (CA)
2
- Name:
- CRANE Sheldon
- Address:
- Canada (CA)
3
- Name:
- MORADEI Oscar, M.
- Address:
- Canada (CA)
4
- Name:
- MCKAY Daniel, J.
- Address:
- United States (US)
5
- Name:
- TRUONG Vouy Linh
- Address:
- Canada (CA)
Priority
- Priority Number:
- 408006 P
- Priority Date:
- 29/10/2010
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 277/62;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|